[Federal Register Volume 68, Number 179 (Tuesday, September 16, 2003)]
[Notices]
[Page 54234]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-23519]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Advisory Council on Drug Abuse.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contract Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: September 17-18, 2003.
    Closed: September 17, 2003, 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, neuroscience center, 6001 
Executive Boulevard, Rockville, MD 20852.

    Open: September 18, 2003, 9 a.m. to 3 p.m.
    Agenda: This portion of the meeting will be open to the public 
for announcements and reports of administrative, legislative and 
program developments in the drug abuse field.
    Place: National Institutes of Health, Neuroscience center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Teresa Levitin, PhD, Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, national 
Institutes of Health, DHHS, Bethesda, MD 20892-9547, (301) 443-2755.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.
    Information is also available on the Institute's/Center's Home 
page: http://www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Training; 93.279, Drug Abuse 
Research Programs, National Institutes of Health, HHS)

    Dated: September 5, 2003.
Anna Snouffer, Acting,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 03-23519 Filed 9-15-03; 8:45 am]
BILLING CODE 4140-01-M